Clinical Trial Update: PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study [Phase 2]

View source ↗

Summary

A Phase II single-center study evaluating PET/MR for restaging in prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED